ATE304008T1 - Benzimidiazole und pyridylimidazole derivate als liganden für gaba rezeptoren - Google Patents
Benzimidiazole und pyridylimidazole derivate als liganden für gaba rezeptorenInfo
- Publication number
- ATE304008T1 ATE304008T1 AT01992307T AT01992307T ATE304008T1 AT E304008 T1 ATE304008 T1 AT E304008T1 AT 01992307 T AT01992307 T AT 01992307T AT 01992307 T AT01992307 T AT 01992307T AT E304008 T1 ATE304008 T1 AT E304008T1
- Authority
- AT
- Austria
- Prior art keywords
- benzimidiazole
- ligands
- gaba receptors
- pyridylimidazole derivatives
- pyridylimidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25749200P | 2000-12-21 | 2000-12-21 | |
PCT/US2001/050038 WO2002050062A2 (en) | 2000-12-21 | 2001-12-21 | Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE304008T1 true ATE304008T1 (de) | 2005-09-15 |
Family
ID=22976520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01992307T ATE304008T1 (de) | 2000-12-21 | 2001-12-21 | Benzimidiazole und pyridylimidazole derivate als liganden für gaba rezeptoren |
Country Status (40)
Country | Link |
---|---|
US (4) | US6916819B2 (de) |
EP (1) | EP1368342B3 (de) |
JP (1) | JP2004536782A (de) |
KR (1) | KR100854174B1 (de) |
CN (1) | CN1553909A (de) |
AP (1) | AP1503A (de) |
AR (1) | AR035774A1 (de) |
AT (1) | ATE304008T1 (de) |
AU (2) | AU2002232768B2 (de) |
BG (1) | BG107899A (de) |
BR (1) | BR0116385A (de) |
CA (1) | CA2431592A1 (de) |
CO (1) | CO5390086A1 (de) |
CZ (1) | CZ20031676A3 (de) |
DE (1) | DE60113302T2 (de) |
EA (1) | EA007157B1 (de) |
EC (1) | ECSP034656A (de) |
EE (1) | EE05108B1 (de) |
EG (1) | EG24590A (de) |
ES (1) | ES2256325T3 (de) |
HR (1) | HRP20030483A9 (de) |
HU (1) | HUP0303849A3 (de) |
IL (1) | IL156294A0 (de) |
IS (1) | IS6855A (de) |
MA (1) | MA26974A1 (de) |
MX (1) | MXPA03005493A (de) |
MY (1) | MY141733A (de) |
NO (1) | NO326558B1 (de) |
NZ (1) | NZ526330A (de) |
OA (1) | OA12539A (de) |
PA (1) | PA8535601A1 (de) |
PE (1) | PE20020720A1 (de) |
PL (1) | PL366243A1 (de) |
SK (1) | SK7672003A3 (de) |
TW (1) | TWI304402B (de) |
UA (1) | UA75902C2 (de) |
UY (1) | UY27095A1 (de) |
WO (1) | WO2002050062A2 (de) |
YU (1) | YU51703A (de) |
ZA (1) | ZA200304544B (de) |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI248936B (en) * | 2001-03-21 | 2006-02-11 | Merck Sharp & Dohme | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
IL159811A0 (en) | 2001-07-13 | 2004-06-20 | Neurogen Corp | Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
WO2003060475A2 (en) | 2002-01-10 | 2003-07-24 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
EP1465888A2 (de) | 2002-01-10 | 2004-10-13 | Neurogen Corporation | Melaninkonzentrierende hormonrezeptorliganden: substituierte benzoimidazol-analoga |
CA2485093A1 (en) * | 2002-05-02 | 2003-11-13 | Neurogen Corporation | Substituted imidazole derivatives: gabaa receptor ligands |
AU2003301864A1 (en) * | 2002-05-08 | 2004-06-07 | Neurogen Corporation | Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands |
JP2006502974A (ja) * | 2002-05-17 | 2006-01-26 | ニューロジェン コーポレイション | 置換環縮合イミダゾール誘導体:gabaa受容体リガンド |
US20040063938A1 (en) * | 2002-09-30 | 2004-04-01 | Pfizer Inc | Process for preparing haloalkyl pyrimidines |
CN100579579C (zh) * | 2002-10-01 | 2010-01-13 | 诺华疫苗和诊断公司 | 抗癌及抗感染性疾病组合物及其使用方法 |
CA2495708A1 (en) * | 2002-11-08 | 2004-05-21 | Neurogen Corporation | 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors |
US20060084682A1 (en) * | 2002-12-13 | 2006-04-20 | Heerding Dirk A | Thrombopoietin mimetics |
US7381825B2 (en) | 2003-03-17 | 2008-06-03 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
SE0301699D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
CA2537331A1 (en) | 2003-07-25 | 2005-02-10 | Neurogen Corporation | Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
CN100457756C (zh) * | 2003-07-25 | 2009-02-04 | 神经能质公司 | 咪唑-嘧啶类及三唑-嘧啶类:苯并二氮平受体配体 |
EP1880998A1 (de) * | 2003-07-25 | 2008-01-23 | Neurogen Corporation | Imidazo-Pyrimide und Triazolo-Pyrimide: Benzodiazepin-Rezeptorliganden |
ATE472534T1 (de) | 2003-09-22 | 2010-07-15 | S | Benzimidazolderivate: herstellung und pharmazeutische anwendungen |
HUP0304101A3 (en) * | 2003-12-22 | 2008-10-28 | Sanofi Aventis | Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates |
WO2005121132A1 (ja) * | 2004-06-11 | 2005-12-22 | Shionogi & Co., Ltd. | 抗hcv作用を有する縮合ヘテロ環化合物 |
KR101022082B1 (ko) | 2005-10-11 | 2011-03-17 | 에프. 호프만-라 로슈 아게 | 아이소옥사졸 유도체 |
JP5015172B2 (ja) | 2005-12-23 | 2012-08-29 | エフ.ホフマン−ラ ロシュ アーゲー | アリール−イソオキサゾロ−4−イル−オキサジアゾール誘導体 |
PL1968973T3 (pl) | 2005-12-27 | 2012-03-30 | Hoffmann La Roche | Pochodne aryloizoksazol-4-iloimidazolu |
RU2426732C2 (ru) | 2006-01-17 | 2011-08-20 | Ф. Хоффманн-Ля Рош Аг | АРИЛ-ИЗОКСАЗОЛ-4-ИЛ-ИМИДАЗО[1,2-a]ПИРИДИН, ПРИГОДНЫЙ ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА ЧЕРЕЗ ПОСРЕДСТВО GABA-РЕЦЕПТОРОВ |
AU2007267183B2 (en) | 2006-05-31 | 2011-10-20 | F. Hoffmann-La Roche Ag | Aryl-4-ethynyl-isoxazole derivatives |
TW200808772A (en) * | 2006-06-13 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
WO2008016123A1 (fr) * | 2006-08-03 | 2008-02-07 | Takeda Pharmaceutical Company Limited | INHIBITEUR DE LA GSK-3β |
WO2008051533A2 (en) * | 2006-10-25 | 2008-05-02 | Takeda Pharmaceutical Company Limited | Benzimidazole compounds |
JP5416103B2 (ja) | 2007-06-22 | 2014-02-12 | エフ.ホフマン−ラ ロシュ アーゲー | イソオキサゾール−イミダゾール誘導体 |
TW200911803A (en) * | 2007-07-16 | 2009-03-16 | Organon Nv | 6-phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives |
BRPI0823262A2 (pt) * | 2007-08-10 | 2013-09-24 | Cortex Pharma Inc | mÉtodo de tratamento de depressço respiratària e uso de um composto na fabricaÇço de um medicamento para o tratamento de depressço respiratària |
US7943619B2 (en) | 2007-12-04 | 2011-05-17 | Hoffmann-La Roche Inc. | Isoxazolo-pyridazine derivatives |
KR101175859B1 (ko) | 2007-12-04 | 2012-08-24 | 에프. 호프만-라 로슈 아게 | 이속사졸로-피라진 유도체 |
US7902201B2 (en) | 2007-12-04 | 2011-03-08 | Hoffmann-La Roche Inc. | Isoxazolo-pyrazine derivatives |
TW201033201A (en) | 2009-02-19 | 2010-09-16 | Hoffmann La Roche | Isoxazole-isoxazole and isoxazole-isothiazole derivatives |
US8389550B2 (en) | 2009-02-25 | 2013-03-05 | Hoffmann-La Roche Inc. | Isoxazoles / O-pyridines with ethyl and ethenyl linker |
US8222246B2 (en) | 2009-04-02 | 2012-07-17 | Hoffmann-La Roche Inc. | Substituted isoxazoles |
US20100280019A1 (en) | 2009-04-30 | 2010-11-04 | Roland Jakob-Roetne | Isoxazoles |
US8410104B2 (en) | 2009-05-05 | 2013-04-02 | Hoffmann-La Roche Inc. | Pyridazines |
WO2010127976A1 (en) | 2009-05-05 | 2010-11-11 | F. Hoffmann-La Roche Ag | Isoxazole-pyridine derivatives |
JP5478716B2 (ja) | 2009-05-05 | 2014-04-23 | エフ.ホフマン−ラ ロシュ アーゲー | 認識障害の処置において使用するためのgabaa受容体逆アゴニストとしてのイソオキサゾール−チアゾール誘導体 |
MX2011011273A (es) | 2009-05-05 | 2011-11-04 | Hoffmann La Roche | Derivados de isoxazol-pirazol. |
KR101354416B1 (ko) | 2009-05-07 | 2014-02-19 | 에프. 호프만-라 로슈 아게 | 감마-아미노부티르산 조절제로서 이속사졸-피리딘 유도체 |
WO2012033149A1 (ja) * | 2010-09-10 | 2012-03-15 | 塩野義製薬株式会社 | Ampk活性化作用を有するヘテロ環縮合イミダゾール誘導体 |
US20130196990A1 (en) | 2010-10-06 | 2013-08-01 | Junya Qu | Benzimidazole Derivatives As PI3 Kinase Inhibitors |
AU2011328993B2 (en) | 2010-11-15 | 2017-03-02 | Agenebio, Inc. | Pyridazine derivatives, compositions and methods for treating cognitive impairment |
MX348131B (es) * | 2011-02-25 | 2017-05-26 | Merck Sharp & Dohme | Novedosos derivados de azabencimidazol ciclico utiles como agentes antidiabeticos. |
WO2012116440A1 (en) | 2011-03-03 | 2012-09-07 | Zalicus Pharmaceuticals Ltd. | Benzimidazole inhibitors of the sodium channel |
CN102653531B (zh) * | 2011-03-04 | 2014-08-13 | 上海爱普植物科技有限公司 | 一种马索亚内酯的合成方法 |
CA2855948C (en) * | 2011-08-11 | 2020-07-28 | Bayer Cropscience Ag | 1,2,4-triazolyl-substituted keto-enols |
US8785435B2 (en) | 2011-10-20 | 2014-07-22 | Hoffmann-La Roche Inc. | Solid forms |
GB201119538D0 (en) * | 2011-11-10 | 2011-12-21 | Viral Ltd | Pharmaceutical compounds |
CN104024234B (zh) | 2012-01-11 | 2016-09-28 | 拜耳知识产权有限责任公司 | 四唑-5-基-和三唑-5-基-芳基化合物及其作为除草剂的用途 |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
WO2013174895A1 (en) | 2012-05-24 | 2013-11-28 | Cellzome Limited | Heterocyclyl pyrimidine analogues as tyk2 inhibitors |
JP6230344B2 (ja) * | 2013-09-06 | 2017-11-15 | 株式会社東芝 | 蒸気タービンプラント |
WO2015052178A1 (en) | 2013-10-10 | 2015-04-16 | Basf Se | 1,2,5-oxadiazole compounds and their use as herbicides |
WO2015052173A1 (en) | 2013-10-10 | 2015-04-16 | Basf Se | Tetrazole and triazole compounds and their use as herbicides |
JP6883988B2 (ja) | 2013-12-20 | 2021-06-09 | エージンバイオ, インコーポレイテッド | ベンゾジアゼピン誘導体、組成物、および認知障害を処置するための方法 |
JP2017504628A (ja) * | 2014-01-31 | 2017-02-09 | 小野薬品工業株式会社 | 縮合イミダゾール化合物 |
TWI675031B (zh) * | 2014-02-17 | 2019-10-21 | 德商拜耳作物科學股份有限公司 | 作為殺蟲劑之2-(雜環)芳基-取代之稠合雙環雜環衍生物 |
WO2016016421A1 (en) * | 2014-07-31 | 2016-02-04 | Institut Pasteur Korea | 2-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin e synthase inhibitors |
CA3210002A1 (en) | 2014-12-29 | 2016-07-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Small molecule inhibitors of lactate dehydrogenase and methods of use thereof |
UY36547A (es) | 2015-02-05 | 2016-06-01 | Bayer Cropscience Ag | Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas |
UY36548A (es) | 2015-02-05 | 2016-06-01 | Bayer Cropscience Ag | Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas |
EP3280716B1 (de) | 2015-04-08 | 2020-02-12 | Bayer CropScience AG | Imidazo[1,2-a]pyridin-2-yl-derivate als schädlingsbekämpfungsmittel und deren zwischenprodukte |
EA036844B1 (ru) | 2015-06-19 | 2020-12-28 | Эйджинбайо, Инк. | Производные бензодиазепина, композиции и способы для лечения когнитивного нарушения |
AU2016297558B2 (en) * | 2015-07-20 | 2021-03-25 | Genzyme Corporation | Colony stimulating factor-1 receptor (CSF-1R) inhibitors |
ES2882667T3 (es) | 2015-08-07 | 2021-12-02 | Bayer Cropscience Ag | Derivados heterocíclicos condensados sustituidos por 2-(het)arilo como pesticidas |
ES2894301T3 (es) | 2015-10-26 | 2022-02-14 | Bayer Cropscience Ag | Derivados de heterociclos bicíclicos condensados como pesticidas |
WO2017093180A1 (de) | 2015-12-01 | 2017-06-08 | Bayer Cropscience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
WO2017144341A1 (de) | 2016-02-23 | 2017-08-31 | Bayer Cropscience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
CN107531679B (zh) * | 2016-03-18 | 2021-07-02 | 江苏恒瑞医药股份有限公司 | 芳香酰胺类衍生物、其制备方法及其在医药上的应用 |
WO2017174414A1 (de) | 2016-04-05 | 2017-10-12 | Bayer Cropscience Aktiengesellschaft | Naphthalin-derivate als schädlingsbekämpfungsmittel |
AR108257A1 (es) | 2016-05-02 | 2018-08-01 | Mei Pharma Inc | Formas polimórficas de 3-[2-butil-1-(2-dietilamino-etil)-1h-bencimidazol-5-il]-n-hidroxi-acrilamida y usos de las mismas |
EP3241830A1 (de) | 2016-05-04 | 2017-11-08 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
KR102435080B1 (ko) | 2016-07-19 | 2022-08-22 | 바이엘 크롭사이언스 악티엔게젤샤프트 | 해충 방제제로서의 축합 바이시클릭 헤테로사이클 유도체 |
EP3497102B1 (de) | 2016-08-15 | 2022-12-07 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
JP7098600B2 (ja) | 2016-08-16 | 2022-07-11 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 3H-イミダゾール[4,5-c]ピリジン誘導体を有機金属亜鉛-アミン塩基と反応させることによる2-(3,6-ジハロピリジン-2-イル)-3H-イミダゾール[4,5-c]ピリジン誘導体及び関連化合物の製造方法 |
AU2017328614B2 (en) | 2016-09-19 | 2022-01-13 | Bayer Aktiengesellschaft | Pyrazolo [1,5-a]pyridine derivatives and their use as pesticides |
JP6994504B2 (ja) | 2016-10-06 | 2022-01-14 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 有害生物防除剤としての2-(ヘタ)アリール置換された縮合二環式複素環誘導体 |
ES2910790T3 (es) | 2016-12-01 | 2022-05-13 | Syngenta Participations Ag | Proceso para la preparación de intermedios de derivados heterocíclicos con actividad plaguicida con sustituyentes que contienen azufre |
BR112019012821A2 (pt) | 2016-12-19 | 2019-11-26 | Agenebio Inc | derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo |
US20180170941A1 (en) | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
WO2018138050A1 (de) | 2017-01-26 | 2018-08-02 | Bayer Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
TW201833107A (zh) | 2017-02-06 | 2018-09-16 | 德商拜耳廠股份有限公司 | 作為殺蟲劑之經2-(雜)芳基取代的稠合雜環衍生物 |
EP3615540B1 (de) | 2017-04-24 | 2022-04-27 | Bayer Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
AU2018344370C1 (en) | 2017-10-04 | 2023-04-27 | Bayer Aktiengesellschaft | Derivatives of heterocyclic compounds as pest control agents |
EP3305786A3 (de) | 2018-01-22 | 2018-07-25 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
JP2021514949A (ja) | 2018-02-21 | 2021-06-17 | バイエル・アクチエンゲゼルシヤフト | 有害生物防除剤としての縮合二環式ヘテロ環誘導体 |
KR20210005081A (ko) | 2018-04-20 | 2021-01-13 | 바이엘 악티엔게젤샤프트 | 해충 방제제로서의 헤테로시클렌 유도체 |
JP7514534B2 (ja) | 2018-06-19 | 2024-07-11 | エージンバイオ, インコーポレイテッド | 認知障害を処置するためのベンゾジアゼピン誘導体、組成物および方法 |
WO2020011086A1 (zh) * | 2018-07-13 | 2020-01-16 | 四川科伦博泰生物医药股份有限公司 | 苯并二氮杂环类化合物、其制备方法及用途 |
EP3636645A1 (de) | 2018-10-11 | 2020-04-15 | Bayer Aktiengesellschaft | Verfahren zur herstellung schwefel-substituierter pyridinderivate |
KR20210133984A (ko) | 2019-02-26 | 2021-11-08 | 바이엘 악티엔게젤샤프트 | 해충 방제제로서의 축합된 비시클릭 헤테로시클릭 유도체 |
US20230060425A1 (en) | 2019-02-26 | 2023-03-02 | Bayer Aktiengesellschaft | Fused bicyclic heterocycle derivatives as pesticides |
AR119140A1 (es) | 2019-06-13 | 2021-11-24 | Pi Industries Ltd | Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas |
CN110407744A (zh) * | 2019-08-13 | 2019-11-05 | 上海毕得医药科技有限公司 | 一种1-(4-氨基吡啶-2-基)乙酮的合成方法 |
CN111072681B (zh) * | 2019-12-11 | 2020-11-06 | 郑州大学 | 一种靶向细胞膜表面gaba受体荧光探针及其制备方法和应用 |
JP2024500919A (ja) | 2020-12-23 | 2024-01-10 | ジェンザイム・コーポレーション | 重水素化コロニー刺激因子-1受容体(csf-1r)阻害剤 |
US20240132513A1 (en) | 2022-08-19 | 2024-04-25 | Agenebio, Inc. | Benzazepine derivatives, compositions, and methods for treating cognitive impairment |
CN115490646A (zh) * | 2022-10-10 | 2022-12-20 | 安徽昊帆生物有限公司 | 3-硝基-1,2,4-三氮唑的制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3150486A1 (de) * | 1981-12-19 | 1983-08-25 | Merck Patent Gmbh, 6100 Darmstadt | Imidazo(4,5-c)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung |
SK282425B6 (sk) | 1995-04-21 | 2002-01-07 | Neurosearch A/S | Benzimidazolové zlúčeniny, farmaceutické zmesi obsahujúce tieto zlúčeniny a použitie týchto zlúčenín |
GB9702524D0 (en) * | 1997-02-07 | 1997-03-26 | Merck Sharp & Dohme | Therapeutic agents |
AU6444298A (en) | 1997-03-04 | 1998-09-22 | Medtronic, Inc. | Bioprothesis film strip for surgical stapler and method of attaching the same |
WO2000059905A1 (en) * | 1999-04-02 | 2000-10-12 | Neurogen Corporation | ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
JP2003528802A (ja) | 1999-04-02 | 2003-09-30 | ニューロゲン コーポレイション | N−ベンゾイミダゾリルメチル−及びn−インドリルメチル−ベンズアミド並びにcrf調節物質としてのそれらの使用 |
CA2369544A1 (en) | 1999-04-02 | 2000-10-12 | Robert W. Desimone | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives:selective modulators of bradykinin b2 receptors |
JP2002541146A (ja) | 1999-04-02 | 2002-12-03 | ニューロゲン コーポレイション | アリールおよびヘテロアリール融合のアミノアルキル−イミダゾール誘導体および糖尿病薬としてのその使用 |
US6512062B1 (en) * | 1999-04-08 | 2003-01-28 | The University Of North Carolina At Chapel Hill | Polymerization of non-fluorinated monomers in carbon dioxide |
IL146403A0 (en) * | 1999-06-22 | 2002-07-25 | Neurosearch As | Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
GB9921150D0 (en) * | 1999-09-07 | 1999-11-10 | Merck Sharp & Dohme | Therapeutic agents |
DE60039921D1 (de) | 2000-09-29 | 2008-09-25 | Neurogen Corp | Hochaffine kleinmolekülige c5a-rezeptor-modulatoren |
AU2001296799A1 (en) | 2000-10-06 | 2002-04-15 | Neurogen Corporation | Benzimidazole and indole derivatives as crf receptor modulators |
US7030150B2 (en) | 2001-05-11 | 2006-04-18 | Trimeris, Inc. | Benzimidazole compounds and antiviral uses thereof |
-
2001
- 2001-12-20 PA PA20018535601A patent/PA8535601A1/es unknown
- 2001-12-21 CZ CZ20031676A patent/CZ20031676A3/cs unknown
- 2001-12-21 UA UA2003065755A patent/UA75902C2/uk unknown
- 2001-12-21 CN CNA018223869A patent/CN1553909A/zh active Pending
- 2001-12-21 AP APAP/P/2003/002818A patent/AP1503A/en active
- 2001-12-21 ES ES01992307T patent/ES2256325T3/es not_active Expired - Lifetime
- 2001-12-21 AT AT01992307T patent/ATE304008T1/de not_active IP Right Cessation
- 2001-12-21 TW TW090131848A patent/TWI304402B/zh not_active IP Right Cessation
- 2001-12-21 SK SK767-2003A patent/SK7672003A3/sk unknown
- 2001-12-21 KR KR1020037008480A patent/KR100854174B1/ko not_active IP Right Cessation
- 2001-12-21 BR BR0116385-0A patent/BR0116385A/pt not_active IP Right Cessation
- 2001-12-21 AR ARP010105998A patent/AR035774A1/es unknown
- 2001-12-21 EE EEP200300304A patent/EE05108B1/xx not_active IP Right Cessation
- 2001-12-21 NZ NZ526330A patent/NZ526330A/en active IP Right Revival
- 2001-12-21 JP JP2002551558A patent/JP2004536782A/ja active Pending
- 2001-12-21 IL IL15629401A patent/IL156294A0/xx unknown
- 2001-12-21 EA EA200300713A patent/EA007157B1/ru not_active IP Right Cessation
- 2001-12-21 MY MYPI20015821A patent/MY141733A/en unknown
- 2001-12-21 AU AU2002232768A patent/AU2002232768B2/en not_active Ceased
- 2001-12-21 CO CO01109589A patent/CO5390086A1/es not_active Application Discontinuation
- 2001-12-21 UY UY27095A patent/UY27095A1/es not_active Application Discontinuation
- 2001-12-21 OA OA1200300157A patent/OA12539A/en unknown
- 2001-12-21 MX MXPA03005493A patent/MXPA03005493A/es active IP Right Grant
- 2001-12-21 EP EP01992307A patent/EP1368342B3/de not_active Expired - Lifetime
- 2001-12-21 HU HU0303849A patent/HUP0303849A3/hu unknown
- 2001-12-21 PL PL01366243A patent/PL366243A1/xx not_active Application Discontinuation
- 2001-12-21 DE DE60113302T patent/DE60113302T2/de not_active Expired - Lifetime
- 2001-12-21 AU AU3276802A patent/AU3276802A/xx active Pending
- 2001-12-21 YU YU51703A patent/YU51703A/sh unknown
- 2001-12-21 CA CA002431592A patent/CA2431592A1/en not_active Abandoned
- 2001-12-21 WO PCT/US2001/050038 patent/WO2002050062A2/en active IP Right Grant
- 2001-12-21 US US10/038,069 patent/US6916819B2/en not_active Expired - Fee Related
- 2001-12-21 PE PE2001001296A patent/PE20020720A1/es not_active Application Discontinuation
- 2001-12-22 EG EG20011360A patent/EG24590A/xx active
-
2003
- 2003-06-11 BG BG107899A patent/BG107899A/bg unknown
- 2003-06-11 ZA ZA2003/04544A patent/ZA200304544B/en unknown
- 2003-06-13 HR HR20030483A patent/HRP20030483A9/xx not_active Application Discontinuation
- 2003-06-16 EC EC2003004656A patent/ECSP034656A/es unknown
- 2003-06-17 MA MA27199A patent/MA26974A1/fr unknown
- 2003-06-20 IS IS6855A patent/IS6855A/is unknown
- 2003-06-20 NO NO20032834A patent/NO326558B1/no not_active IP Right Cessation
-
2005
- 2005-07-12 US US11/179,458 patent/US7300945B2/en not_active Expired - Fee Related
-
2007
- 2007-11-19 US US11/942,480 patent/US7642267B2/en not_active Expired - Fee Related
-
2010
- 2010-01-05 US US12/652,435 patent/US20100267698A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE304008T1 (de) | Benzimidiazole und pyridylimidazole derivate als liganden für gaba rezeptoren | |
DE60207815D1 (de) | 1-aryl-oder 1-alkylsulfonylbenzazol derivate als 5-hydroxytryptamin-6 liganden | |
ATE387428T1 (de) | Chinolinderivate als liganden für den neuropeptid-y-rezeptor | |
DE60336811D1 (de) | Neue benzimidazolderivate | |
DE60020812D1 (de) | Heteroaryl-substituierte chinolin-2-on derivate verwendbar als antikrebsmittel | |
ATE359275T1 (de) | Substituierte bizyclische derivate verwendbar als antitumor mittel | |
DE69920009D1 (de) | Isothiazole derivate verwendbar als antikrebsmittel | |
ATE253067T1 (de) | Diazabicyloderivate als nikotin-acetylcholin- rezeptorliganden | |
DE50110649D1 (de) | Zubereitung für restenoseprophylaxe | |
ATE396191T1 (de) | Azaindolylalkylaminderivate als 5- hydroxytryptamin-6-liganden | |
DE60025960D1 (de) | Motorprüfgerät | |
DE60107221D1 (de) | Indolin-2-on derivate und deren verwendung als liganden der ocytocin rezeptoren | |
ATE421506T1 (de) | Neue benzimidazolderivate | |
ATE327232T1 (de) | Heterozyklylalkylindole oder -azaindole als 5- hydroxytryptamine-6 liganden | |
ATE335477T1 (de) | Indolylalkylamin-derivate als 5-hydroxytryptamin- 6 liganden | |
ATE273980T1 (de) | 6-phenylpyrrolopyrimidindion derivate | |
DE60206017D1 (de) | Abdeckung für bohrlochfilter | |
DE60227606D1 (de) | Verstellbare Schaufel für Turbomaschinen | |
DE60137061D1 (de) | Platin-verbindungen als antitumorwirkstoffe | |
DE60109384D1 (de) | Messapparat für Riemenscheibe | |
DE602004028821D1 (de) | Pyrrolidiniumderivative als liganden für den muscarinen m3-rezeptor | |
DE60033834D1 (de) | Für periphäre cannabinoid-rezeptoren selektive liganden | |
AU4439801A (en) | Pyrazolo-triazine derivatives as ligands for gaba receptors | |
ATE254621T1 (de) | Thienoisoxazolyl- und thienylpyrazolyl-phenoxy substituierte propyl derivate als d4 antagonisten | |
ATE325123T1 (de) | Imidazoquinoline derivate als adenosine a3 rezeptor liganden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |